Eschenbach Andrew C. von's Net Worth

$1.4 Million

Estimate Recalculated Oct 6, 2025 08:51PM EST

Who is Eschenbach Andrew C. von

Eschenbach Andrew C. von has an estimated net worth of $1.4 Million. This is based on reported shares across multiple companies, which include Celularity Inc, Bausch Health Companies Inc., Radius Health, Inc., BIOTIME INC, Asterias Biotherapeutics, Inc., Bausch & Lomb Corp, and TriSalus Life Sciences, Inc..

SEC CIK

Eschenbach Andrew C. von's CIK is 0001536529

Past Insider Trading and Trends

2021 was Eschenbach Andrew C. von's most active year for acquiring shares with 7 total transactions. Eschenbach Andrew C. von's most active month to acquire stocks was the month of June. 2022 was Eschenbach Andrew C. von's most active year for disposing of shares, totalling 2 transactions. Eschenbach Andrew C. von's most active month to dispose stocks was the month of July. 2019 saw Eschenbach Andrew C. von paying a total of $249,981.83 for 10,633 shares, this is the most they've acquired in one year. In 2022 Eschenbach Andrew C. von cashed out on 15,500 shares for a total of $91,000.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Celularity Inc

Investor
Updated Jun 16, 2023
Form 4
350.88%
477.70K
Jun 16, 2023
613.84K
Grant
Jun 14
Form 4
90.30%
90.30K
Jul 15, 2022
190.30K
Grant
Jul 13
Form 4
$0.28
$28.00K
Dec 02, 2021
307.44K
Options
Nov 09
Form 4
56.05K
Sep 13, 2021
56.05K
Grant
Sep 09
Form 4
576.44K
Jul 20, 2021
576.44K
Grant
Jul 16
Form 3
Jul 16, 2021
Showing 6 results

Bausch Health Companies Inc.

Investor
Updated Aug 09, 2021
Form 4
3.76%
1.40K
$25.94
$36.32K
Aug 09, 2021
38.65K
Purchase
Aug 05
Form 4
25.83%
7.64K
May 03, 2021
37.25K
Grant
Apr 30
Form 4
59.45%
11.04K
May 01, 2020
29.60K
Grant
May 01
Form 4
6.30%
1.10K
$18.18
$20.00K
Mar 11, 2020
18.57K
Purchase
Mar 10
Form 4
155.64%
10.63K
$23.51
$249.98K
May 03, 2019
17.47K
Grant
May 03
Form 4
583.20%
5.83K
Oct 31, 2018
6.83K
Grant
Oct 29
Form 3
Oct 31, 2018
1.00K
Showing 7 results

Radius Health, Inc.

Investor
Updated Aug 15, 2022
Form 4
-100.00%
-15.50K
$6.80
-$91.00K
Aug 15, 2022
Disposition
Aug 15
Form 4
15.50K
Jan 25, 2022
15.50K
Grant
Jan 14
Form 4
30.00K
Jan 05, 2021
30.00K
Grant
Jan 04
Form 3
Jan 05, 2021
Showing 4 results

BIOTIME INC

Investor
Updated Aug 14, 2013
Form 4
3.00K
$3.69
$11.07K
Aug 14, 2013
63.00K
Purchase
Aug 12
Form 4
20.00K
Jul 05, 2013
60.00K
Grant
Jul 01
Form 4
20.00K
Jul 03, 2012
40.00K
Grant
Jul 01
Form 3
Dec 07, 2011
Showing 4 results

Asterias Biotherapeutics, Inc.

Investor
Updated Apr 03, 2014
Form 4
20.00K
Apr 03, 2014
40.00K
Acq/Dis
Apr 01
Form 3
Sep 27, 2013
Showing 2 results

Bausch & Lomb Corp

Investor
Updated May 05, 2023
Form 4
102.86%
12.86K
May 05, 2023
25.36K
Grant
May 04
Form 4
12.50K
May 12, 2022
12.50K
Grant
May 10
Form 3
May 05, 2022
Showing 3 results

TriSalus Life Sciences, Inc.

Investor
Updated Jun 05, 2024
Form 4
Jun 05, 2024
35.00K
Grant
Jun 03
Form 4
35.00K
Aug 14, 2023
35.00K
Grant
Aug 10
Form 3
Aug 14, 2023
Showing 3 results